{"organizations": [], "uuid": "c80621e84c749eddc722797707053fd57957f32e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-spark-therapeutics-says-entered-in/brief-spark-therapeutics-says-entered-into-asset-purchase-agreement-with-jazz-pharmaceuticals-ireland-ltd-idUSFWN1S70Q1", "country": "US", "domain_rank": 408, "title": "BRIEF-Spark Therapeutics Says Entered Into Asset Purchase Agreement With Jazz Pharmaceuticals Ireland Ltd", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-30T14:51:00.000+03:00", "replies_count": 0, "uuid": "c80621e84c749eddc722797707053fd57957f32e"}, "author": "", "url": "https://www.reuters.com/article/brief-spark-therapeutics-says-entered-in/brief-spark-therapeutics-says-entered-into-asset-purchase-agreement-with-jazz-pharmaceuticals-ireland-ltd-idUSFWN1S70Q1", "ord_in_thread": 0, "title": "BRIEF-Spark Therapeutics Says Entered Into Asset Purchase Agreement With Jazz Pharmaceuticals Ireland Ltd", "locations": [], "entities": {"persons": [], "locations": [{"name": "ireland", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "jazz pharmaceuticals ireland ltd reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 30, 2018 / 11:55 AM / Updated 21 minutes ago BRIEF-Spark Therapeutics Says Entered Into Asset Purchase Agreement With Jazz Pharmaceuticals Ireland Ltd Reuters Staff\nApril 30 (Reuters) - Spark Therapeutics Inc:\n* SPARK THERAPEUTICS SAYS ENTERED INTO ASSET PURCHASE AGREEMENT WITH JAZZ PHARMACEUTICALS IRELAND LIMITED - SEC FILING\n* SPARK THERAPEUTICS - PURSUANT TO AGREEMENT CO AGREED TO SELL RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER\n* SPARK THERAPEUTICS - JAZZ WILL PAY CO $110 MILLION FOR PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER UPON CLOSING OF PURCHASE - SEC FILING Source text: [ bit.ly/2HCWVjZ ] Further company coverage:", "external_links": ["https://bit.ly/2HCWVjZ"], "published": "2018-04-30T14:51:00.000+03:00", "crawled": "2018-04-30T15:10:07.000+03:00", "highlightTitle": ""}